Chagas' disease, which is estimated to afflict 20 million people in Central and South America, is caused by the protozoan parasite 7iyputiosotiiir crirzi. Although drugs currently available to treat the disease, nifurtimox (Lampit j and benznidazole (Radanil), may help to ameliorate the acute parasitaemic phase of the disease, they are totally ineffective at controlling the chronic phase; therefore much better chemotherapeutic agents are needed. Unlike the related organism 7: hrircei, which causes African trypanosomiasis, the growth o f 7: c w z i is not affected by the ornithine de- GBq/mmol), respectively. For the assays, 0.3 ml o f the lysis buffer containing 1 mM-EDTA and 0.5 mM-i.-[ I-I'CIornithine at 82.3 MBq/mmol for the ODC assay. and 4.5 rnM-MgSO, and 0.5 mM-L-lU-"C]-arginine at 4 9 3 MBq/ mmol for the A D C assay, was prewarmed t o 37°C in a 3 ml test tube closed with a subaseal stopper. The tube contained a I x 2.5 em filter paper soaked in 0.01 ml o f hyamine hydroxide. To start the reaction 0 . I ml of the cell homogenate was injected through the stopper, mixed and incubated at 37°C for 1 h. T h e reaction was terminated by injecting 0.05 ml 100% (w/v) trichloracetic acid into the tube and incubating for a further 1 h. T h e filter paper was then removed and the amount of incorporated "C02 counted by liquid scintillation. For the determination of arginase, the method of Slocum et ul. [9] was followed. T h c method of Conconi bi Grazi [ 101 was used for the determination of glycine amidinotransferase except that the reaction mixture was assayed by h.p.1.c. to determine whether D F M O and guanidineacetic acid were formed. Table I . Putrescine content fell to zero and the total spermidine content was significantly lowered by both D F M O and DFMA (66.2% and 78.5% of control. respectively). Neither spcrminc nor agmatine were dctected in the cells in any of the treatment protocols. T h e amounts of glutathione and trypanothione were not significantly affected, although the amounts of glutathionylspermidine were reduced by both D F M O and D F M A (22.0% and 24.3%) of control. respectively), substantially accounting for the fall .in total sperrnidine. As both D F M O and DFMA were effective in reducing cell growth by a polyamine-dependent mechanism, the amounts of their target enzymes, O D C and ADC, were assaycd by measuring the release of "COZ from the radiolabelled precursor amino acids. Under the conditions described, an activity o f 63.1 pmol/min per mg of protein was observed for O D C which was reduced to 0.53 pmol/min per mg of protein (YY.2'/0 inhibition) when the assay mixture contained I0 mM-DFMO. Unexpectedly, ODC activity was also slightly, but significantly inhibited by 1 0 mM-DFMA (40.4 pmol/min per rng of protein; 21.7% inhibition). T h e cell homogenate also appeared to contain a trace of A D C activity ( 1.19 pmol/min per mg of protein). However, this activity was reduced on incubation with both D F M O and DFMA (69.7% and 94. lo/, inhibition; respectively) and was abolished completely when incubated with 10 mM-ornithine. 
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IIFMA: This suggests that IJCO2 release from arginine is not due to A D C itself, but occurs via conversion of arginine to ornithine, which is then decarboxylated by ODC. To test this hypothesis, cell homogenates were assayed for the presence of arginase, the enzyme responsible for the conversion of arginine to ornithine with the production of urea. At an arginine concentration of 0.5 mM, a specific activity of 1.5 nmol/min per mg of protein was observed. nearly 24 times higher than for ODC. Addition of 1 unit of urease t o the A D C incubation mixture produced a greatly increased rclease of "CO,, suggesting that the uniformly labclled arginine used in the assay was converted to urea, which was then metabolized to ammonia and radiolabelled CO,. These results, taken together with the finding that agmatine will not reverse DFMA-induced growth inhibition and cannot be dctected in growing cells, demonstrates that A D C is not present in C'. fiscieirlutu. Although difficult to quantify by h.p.1.c. due to its coelution with another peak, D F M O can be observed in both DFMO-and DFMA-treated cells (Table I ) and this could be confirmed by two-dimensional t.1.c. using dansylated cell extracts run on polyamide plates. Therefore, it was concluded that the cells were able to convert DFMA to D F M O and that this could be the cause of the growth inhibition caused by DFMA. To investigate this possibility, [ 3,4- When a cell extract was assayed for glycine amidinotransferase activity, the enzyme that converts arginine to ornithine with the concomitant production of guanidineacetic acid from glycine, no conversion of DFMA to D F M O was observed, inasmuch as no D F M O or guanidineacetic acid were detected by h.p.1.c. analysis of the reaction mixture. Experiments in which [3,4-jH] -DFMA was added to cell cultures and the lysates Vol. 18 assayed for "-DFMO, proved inconclusive due to negligible uptake of the small amounts of label available, so the mechanism by which the conversion of DFMA to DFMO takes place cannot be resolved.
From this study, it can be concluded that DFMO reduces cell growth in C' . fusciculutu by inhibition of ODC, with the resultant depletion o f intracellular polyamines. Although DFMA also slows cell growth, this is not due to inhibition of ADC. but rather inhibition of ODC caused by the metabolic convcrsion of DFMA to DFMO. Work is now continuing on the effects o f DFMO and DFMA o n 7: cnrzi grown in a completely defined medium.
